The Relative Frequency Of Small Vessel Cerebrovascular Disease And Brain Atrophy In MRI Of Patients With Psoriasis

Sahar Dadkhahfar; Mozhdeh Gheisari; Zahra Mahboubi-Fooladi; Mohahmmad Shahidi Dadras

doi:10.5826/dpc.1301a43

The Relative Frequency Of Small Vessel Cerebrovascular Disease And Brain Atrophy In MRI Of Patients With Psoriasis

Authors

Sahar Dadkhahfar Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Mozhdeh Gheisari Department of Radiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Zahra Mahboubi-Fooladi Department of Radiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Mohammad Shahidi-Dadras Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Keywords:

psoriasis, SVCD, MTA, GCA, Fazekas

Abstract

Introduction: Psoriasis is a systemic autoimmune disease that is associated with numerous comorbidities.

Objective: This study aimed to compare the prevalence of small vessel cerebrovascular disease (SVCD) and atrophic brain changes in MRI of patients with psoriasis and normal subjects.

Materials and Methods: This case-control study was performed on 27 patients with psoriasis and 27 normal individuals who were referred to Shohada-e-Tajrish Hospital, Tehran, Iran during 2019 and 2020. Basic demographic and clinical information of participants were recorded. Brain MRI was performed for all individuals to examine the medial temporal atrophy (MTA) score, global cortical atrophy (GCA) score, and Fazekas scale. Finally, the relative frequencies of each parameter between the two groups were compared.

Results: There was no significant difference in the frequency of the Fazekas scale, GCA, and MTA scores between the two groups. However, a mild trend was found for higher frequency of Fazekas scale, GCA, and MTA scores in controls in comparison with the case group. While there was no significant relationship between the Fazekas scale and disease duration (p=0.16), a significant and positive correlation was found between disease duration and GCA and MTA scores (p<0.001). There was no significant relationship between Fazekas, GCA and MTA status and other parameters.

Conclusion: The increase in disease duration was significantly associated with increase in the incidence of cerebral atrophy, which may suggest the need for screening in terms of CNS involvement in psoriasis patients.

Author Biographies

Sahar Dadkhahfar, Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

sahar dadkhahfar and mozhdeh gheisari has similar rolles in this study and are first and co-first authors.

Mozhdeh Gheisari, Department of Radiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mozhdeh Gheisari and Sahar Dadkhahfar are first and co-first authors in this study.

References

Bazsó A, Szodoray P, Szappanos Á, Korda J, Pálfi P, Kiss E, et al. Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature. Mediators of Inflammation. 2015;2015:657907.

Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clinics in dermatology. 2018;36(1):21-8.

Lu R, Aziz NA, Diers K, Stöcker T, Reuter M, Breteler MMB. Insulin resistance accounts for metabolic syndrome-related alterations in brain structure. Human brain mapping. 2021;42(8):2434-44.

Pezzolo E, Mutlu U, Vernooij MW, Dowlatshahi EA, Gisondi P, Girolomoni G, et al. Psoriasis is not associated with cognition, brain imaging markers, and risk for dementia: The Rotterdam Study. Journal of the American Academy of Dermatology. 2021;85(3):671-80.

Engin B, Keçici AS, Uzun A, Yalçın M. Psychiatric comorbidity, depression, and anxiety levels and quality of life of the patients with mycosis fungoides. Dermatologic therapy. 2020:e13922.

Goldman L, Wilson RG, Hornby P, Meyer RG. RADIATION FROM A Q-SWITCHED RUBY LASER. EFFECT OF REPEATED IMPACTS OF POWER OUTPUT OF 10 MEGAWATTS ON A TATTOO OF MAN. The Journal of investigative dermatology. 1965;44:69-71.

Chowdri NA, Mattoo MMA, Darzi MA. Keloids and hypertrophic scars: results with intra‐operative and serial postoperative corticosteroid injection therapy. Australian and New Zealand journal of surgery. 1999;69(9):655-9.

Wolfe F, Michaud K. The effect of methotrexate and anti–tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person‐years of observation. Arthritis & Rheumatism. 2007;56(5):1433-9.

Fung MA, Sharon VR, Ratnarathorn M, Konia TH, Barr KL, Mirmirani P. Elastin staining patterns in primary cicatricial alopecia. J Am Acad Dermatol. 2013;69(5):776-82.

Frank O, Nestle M, Daniel H, Kaplan M, Barker J. Mechanisms of Disease: Psoriasis. N Engl J Med. 2009;361:496-509.

Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T, editors. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. Journal of Investigative Dermatology Symposium Proceedings; 2004: Elsevier.

Chen G, Chen ZM, Fan XY, Jin YL, Li X, Wu SR, et al. Gut-Brain-Skin Axis in Psoriasis: A Review. Dermatology and therapy. 2020.

Brown G, Koo J. Severe Plaque Psoriasis May Have Associated Cognitive Impairment. Dermatology. 2020.

Innamorati M, et al. Cognitive impairment in patients with psoriasis: A matched case-control study. Journal of Psychosomatic Research. 2018.

Najafi P, et al. Functional and anatomical brain connectivity in psoriasis patients and healthy controls: A pilot brain imaging study after exposure to mentally-induced itch. JEADV. 2020;34:2557-65.